Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Stephen Tindal
Advertisement
Stephen Tindal is director, Formulation and Site R&D Lead at Catalent Pharma Solutions.
Articles by Stephen Tindal
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.
Advertisement
Latest Updated Articles
Opportunities with SoftgelsPublished: August 1st 2014 | Updated:
Bridging the Gap from Molecule to DrugPublished: April 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
